Keyphrases
Melanoma
100%
Non-genomic
100%
Non-immune
100%
Genomic Evolution
100%
MAPK Inhibitors
100%
Inhibitor Resistance
100%
Immune Evolution
100%
Tumoral
75%
Acquired Resistance
75%
Tumor Cells
50%
Physiologic
50%
Inhibitor Therapy
50%
Genetic Modification
25%
Cellular Compartments
25%
Non-canonical Pathway
25%
Cell-intrinsic
25%
Disease Progression
25%
Cytolytic T Cells
25%
Drug-resistant Tumor
25%
CD8+ T Cells
25%
Transcriptomics
25%
Methylome
25%
Antigen Presentation
25%
Co-evolving
25%
CpG Sites
25%
Melanocytic Tumor
25%
Highly Dynamic
25%
Differential Methylation
25%
T Cell Depletion
25%
Cross-resistance
25%
Yes-associated Protein 1 (YAP1)
25%
Patient Matched
25%
C-Met
25%
LEF1
25%
Genomic Mechanisms
25%
Infra
25%
T-cell Inflammation
25%
Comparative Transcriptomics
25%
Anti-PD-1 Immunotherapy
25%
Immune Composition
25%
Medicine and Dentistry
Melanoma
100%
Mitogen-Activated Protein Kinase
100%
Neoplasm
40%
Tumor Cell
40%
Transcriptomics
40%
Disease Exacerbation
20%
Progressive Disease
20%
Antigen Presentation
20%
Lymphoid Enhancer Factor 1
20%
Cross Resistance
20%
Programmed Death-Ligand 1
20%
T Cell
20%
Cytotoxic T-Cell
20%
Cell Compartment
20%
Immunotherapy
20%
Methylation
20%
Coevolution
20%
Biochemistry, Genetics and Molecular Biology
Mitogen-Activated Protein Kinase
100%
Genomics
100%
Transcriptomics
50%
Methylation
25%
PD-L1
25%
YAP1
25%
T Cell Deficiency
25%
CpG Site
25%
Cross Resistance
25%
Antigen Presentation
25%
Lymphoid Enhancer-Binding Factor 1
25%
T Cell
25%
CD8
25%
Coevolution
25%